Pancreatic cancer surgery is the experience of one center.

Pancreatic cancer is a malignant tumor originating from the pancreatic epithelium. Despite constant efforts and intensive research, it has not yet been possible to identify risk factors that significantly affect the early diagnosis and effectiveness of pancreatic cancer treatment. In the Russian Federation in 2021, 15055 patients with pancreatic cancer were identified, of which stage III -16.9%, stage IV -58.2%. Mortality in the first year of life from the moment of diagnosis was 65.1%. A total of 1,856 patients underwent radical surgical treatment. Features of the clinical picture of prostate cancer a long latent course and similarity with the clinic of chronic pancreatitis can cause late diagnosis of the disease. In about 70% of cases, the disease is manifested by the syndrome of mechanical jaundice, which requires additional invasive methods of diagnosis and treatment. At the time of diagnosis verification, 80-85% of patients are already inoperable due to local or remote spread of the tumor process. The average life expectancy of patients with unresectable pancreatic cancer is about 6-7 months. After radical surgical treatment, the 5-year survival rate of patients with this pathology, according to the results of various authors, ranges from 0 to 30%.